Automated Breast Ultrasound System (abus) Market
Automated Breast Ultrasound System (abus) Market - Global Industry Assessment & Forecast
#
Pages:
167
2022
Feb - 2022
VMR-1313
Segments Covered
By
Product Automated Breast Ultrasound System, Automated Breast Volume Scanner, Others
-
By
Application Hospitals, Diagnostics Imaging Laboratories, Clinics, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 816.39 Million |
 Revenue 2030:
|
USD 2639.78 Million |
 Revenue CAGR
(2023 - 2030): |
15.80% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Market Synopsis:
Global Automated Breast Ultrasound System (ABUS) market is valued at USD 816.39 Million in 2022 and is projected to attain a value of USD 2639.78 Million by 2030 at a CAGR of 15.80% during the forecast period, 2022–2028. Patients may experience discomfort as a result of chemotherapy equipment. The needle or guide wire can damage the top of the lung during the insertion of a skin-tunneled catheter or port, generating an air pocket. There may be bruising at the location where the needle entered the vein, or an artery or nerve may be damaged. Furthermore, infection is a possibility. The risk is usually one to three in every 100 instances, although it might be higher based on a variety of other circumstances, such as diagnosis or therapy. There's also the possibility of a clot forming around the port. The CVAD can split, become damaged, or become dislocated if it is not in the proper position, so it must be replaced.
Ultrasound examines organs and structures inside the body using high-frequency sound waves. There is no radiation involved with this method. A transducer that scans the entire breast is used in automated breast ultrasonography to obtain three-dimensional (3D) ultrasound pictures for cancer diagnosis.
Technology Advancement
Automated Breast Ultrasound System (ABUS) Market Size, 2022 To 2030 (USD Million)
AI (GPT) is here !!! Ask questions about Automated Breast Ultrasound System (ABUS) Market
One of the primary factors boosting the worldwide automated breast ultrasound system market is technological advances in breast cancer detection equipment. Several additional technologies are being developed by companies to improve cancer screening in people with thick breasts, enhancing the efficiency of breast cancer detection. ABUS innovations are also expected to solve flaws in traditional systems. Customer acceptance of improved cancer imaging will increase as a result of such technological advancements, boosting industry growth.
Stringent Regulations
The use of automated breast ultrasound imaging techniques has been restricted in a number of countries due to rigorous laws. Furthermore, the high cost of ultrasound systems in comparison to traditional cancer screening methods is likely to stifle the global automated breast ultrasound system (ABUS) market's growth. For example, a new ABUS can cost around $300,000 on average. Although ultrasonography is speedy and effective in detecting cancer, it is also prone to false-positive biopsies, which is predicted to limit market growth.
The Automated Breast Ultrasound System (ABUS) market scope can be tabulated as below:
Market Segmentation:
The Global Automated Breast Ultrasound System (ABUS) Market can be segmented by Product into Automated Breast, Ultrasound System, Automated Breast Volume Scanner and Others. Based on Application into Hospitals, Diagnostics Imaging Laboratories, Clinics and Others. Based on Region, the Automated Breast Ultrasound System (ABUS) Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Below tree is interactive. You can click the nodes to get more information.
North America to Continue Dominating the Automated Breast Ultrasound System (ABUS) Market
Because of the rising incidence of cancer and the presence of key competitors in the region, North America accounted for the greatest revenue share in 2021. Furthermore, even women without a history of cancer are advised to begin mammograms when they reach the age of 40 or 50, according to US screening standards. They are also advised to continue once every one or two years, and this is done on a regular basis until the age of 75. This is a crucial aspect that is predicted to promote market expansion in the region in the future. Based on these figures and projections, the market in the region is likely to grow at a high rate in the future.
Key Players:
Key participants operating in the Automated Breast Ultrasound System (ABUS) market are: GE Healthcare (US), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd. (Japan), and SonoCine Inc. (US).
The Automated Breast Ultrasound System (ABUS) market is segmented as follows:
| Parameter | Details |
|---|---|
| Segments Covered |
|
| Regions & Countries Covered |
|
| Companies Covered |
|
| Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis |
FAQ
Frequently Asked Question
What is the global demand for Automated Breast Ultrasound System (ABUS) in terms of revenue?
-
The global Automated Breast Ultrasound System (ABUS) valued at USD 816.39 Million in 2022 and is expected to reach USD 2639.78 Million in 2030 growing at a CAGR of 15.80%.
Which are the prominent players in the market?
-
The prominent players in the market are GE Healthcare (US), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd. (Japan), and SonoCine Inc. (US)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 15.80% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Automated Breast Ultrasound System (ABUS) include
- Technology Advancement
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Automated Breast Ultrasound System (ABUS) in 2022.
